Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Dramatic responses to Iressa prompted further bench research. Results have limited clinical relevance, for now, but findings may explain failure of INTACT studies.
This article is from
The Cancer Letter
archive.
Vol. 30 No. 18 | April 30, 2004
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Health Organizations Endorse “Patients’ Rights” Document
November 17, 1995
TCL Archive
Advances In Cancer Control Meeting Is Set For March 22
February 3, 1989
TCL Archive
ACS Asks Congress For $1.32 Billion NCI ’87 Budget
April 4, 1986
TCL Archive
Dipersio Is Chief Of Oncology At Washington University.
July 14, 2000
TCL Archive
BMS, Exelixis To Collaborate On Drug Development.
July 27, 2001
TCL Archive
HEW Says Patent Delays Temporary
August 25, 1978